95% umano na epektibo ang Russia's Sputnik V Coronavirus vaccine ayon na din resulta ng pangalawang interim analysis nito.
Ang two-dose vaccine nito ay available na sa international markets na nagkakahalagang 8.40 euros o mahigit kumalang na 500 pesos, ngunit libre lang umano ito sa mga mamamayan ng Russia.
Ang mga kalkulasyon ng pagiging epektibo nito ay batay lamang sa paunang data na nakuha nito, 42 na araw pagkatapos ng unang dosis, ayon na sa pahayag ng Russia's health ministry, the state-run Gamaleya research center at the Russian Direct Investment Fund (RDIF).
Nagpakita ng 91.4 % ang pagiging epektibo nito 28 days matapos sa first dose batay sa 39 cases nito.
Pagkalipas ng apatnapu't dalawang araw, data showed "an efficacy of the vaccine above 95 percent."
"The second analysis was conducted a week after volunteers got the second dose, meaning that their bodies have partially reacted to both doses," - Pahayag ng Gamaleya's director Alexander Gintsburg
He said the center expects the efficacy rate to be "even higher" three weeks after the second dose.
The statement said that 22,000 volunteers had been vaccinated with the first dose and more than 19,000 with both doses.
Production for PHL
Manila’s Ambassador to Moscow Carlos Sorreta on Monday said Russia can begin the production of its COVID-19 vaccine candidate intended for the Philippines as early as January next year if the country is ready to accept them.
The Philippines plans to purchase an initial 50 million doses of COVID-19 vaccines next year. Priority will be given to the poor, security forces, government frontline workers and health care workers.
In August, the Philippines said it was ready to work with Russia on clinical trials, vaccine supply and production, and “other areas deemed practicable” by relevant Philippine and Russian agencies to address the COVID-19 crisis.
President Rodrigo Duterte has repeatedly said he preferred vaccines being developed by Russia and China because other countries allegedly asked for advance payment.
